The Paris Center for Microbiome Medicine (PaceMM), a consortium of institutions created to facilitate gut microbiome research, connects 52 partners in the Paris area that are part of the Publique Hôpitaux de Paris, the National Institute for Health and Medical Research (INSERM), the French National Research Institute for Agriculture, Food and the Environment (INRAE), the French Alternative Energies and Atomic Energy Commission (CEA) and several educational institutions such as Sorbonne University. This group seeks to capitalize on the growing expansion of microbiome science worldwide with a goal of better understanding the impact of commensal microbes found inside and on us have on the proper functioning of a wide range of ecosystems, from ocean to gastrointestinal tract.
Gut Microbiota for Health (GMFH) recently published a brief interview with Professor Harry Sokol concerning the new PaceMM, which came to be due to 1) exponential data supporting the microbiome’s role in disease; 2) similarity of disease in how they impact a plethora of medical fields in terms of concepts, methodologies, etc. and 3) overcome the compartmentalized existing microbiome research in the Paris region. Paris is the social, economic professional and pollical nexus of France, and the microbiome research community has recognized this: the birth of PaceMM. See professor Sokol’s Twitter feed.